What's in a Name? For a Drug Maker, It Could Mean Big Profits
Wall Street Journal-5 hours agoFor their part, generic drug makers believe that different names for biosimilars may confuse prescribers and pharmacists as they sort out whether the medicines ...
No comments:
Post a Comment